Methyl 2-(8-iodo-6-(trifluoromethyl)imidazo[1,2-a]pyridin-2-yl)acetate

Catalog No.: 
ACIWGU992
CAS No.: 
1092352-47-0
Molecular Formula: 
C11H8F3IN2O2
Molecular Weight: 
384.10
Methyl 2-(8-iodo-6-(trifluoromethyl)imidazo[1,2-a]pyridin-2-yl)acetate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$125.00InquiryInquiry
1g95%$379.00InquiryInquiry
5g95%$1876.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameMethyl 2-(8-iodo-6-(trifluoromethyl)imidazo[1,2-a]pyridin-2-yl)acetate
IUPAC Namemethyl 2-(8-iodo-6-(trifluoromethyl)imidazo[1,2-a]pyridin-2-yl)acetate
MDL No.MFCD11553037
Molecular FormulaC11H8F3IN2O2
Molecular Weight384.10
SMILESO=C(OC)CC1=CN2C=C(C(F)(F)F)C=C(I)C2=N1
InChI KeyHRHUMTJCPYZLKV-UHFFFAOYSA-N
Synonymmethyl 2-[8-iodo-6-(trifluoromethyl)imidazo[1,2-a]pyridin-2-yl]acetate;Imidazo[1,2-a]pyridine-2-acetic acid, 8-iodo-6-(trifluoromethyl)-, methyl ester
CAS No.1092352-47-0

Synthetic Route by SureRoute

1. ACIWGU992 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACQVKH312 route compound structure diagram
    ACQVKH3121184-54-9In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACIWGU992 route product structure diagram
    ACIWGU9921092352-47-0
Inquiry

2. ACIWGU992 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACIWGU992 route product structure diagram
    ACIWGU9921092352-47-0
Inquiry

3. ACIWGU992 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACIWGU992 route product structure diagram
    ACIWGU9921092352-47-0
Inquiry

Comments (0)